Literature DB >> 12645672

Clinical variables and genetic loading for schizophrenia: analysis of published Danish adoption study data.

Alastair G Cardno1, Katherine Thomas, Peter McGuffin.   

Abstract

Schizophrenia shows considerable clinical variation, but the relationship between clinical variables and degree of genetic loading for schizophrenia is unclear. We investigated this by analyzing published data from the adoption study of Kety et al. (1994) in Denmark. We sought to determine which clinical variables in proband adoptees with chronic schizophrenia predicted risk of schizophrenia in their biological relatives, using logistic regression analysis. We found that risk of chronic schizophrenia in relatives was predicted by the presence of pervasive negative symptoms (odds ratio [OR] = 9.44, 95% confidence interval [CI] = 1.98-45.01) and absence of pervasive positive symptoms (OR = 0.09, 95% CI = 0.01-0.78) in probands. Pervasive negative symptoms were defined by the presence of all of the symptoms: social withdrawal, autistic behavior, poverty of thought/speech, and flat affect. Pervasive positive symptoms were defined by the presence of all of the symptoms: suspiciousness/ideas of reference, delusions, auditory hallucinations, and other hallucinations. These clinical variables may be useful for refining phenotypic definitions of schizophrenia in molecular genetic studies.

Entities:  

Mesh:

Year:  2002        PMID: 12645672     DOI: 10.1093/oxfordjournals.schbul.a006948

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  7 in total

Review 1.  How does studying schizotypal personality disorder inform us about the prodrome of schizophrenia?

Authors:  Katherine Seeber; Kristin S Cadenhead
Journal:  Curr Psychiatry Rep       Date:  2005-03       Impact factor: 5.285

2.  Franz Josef Kallmann (1897-1965).

Authors:  Stephen Pow; Frank W Stahnisch
Journal:  J Neurol       Date:  2016-07-19       Impact factor: 4.849

3.  Neuregulin 1 and age of onset in the major psychoses.

Authors:  Daphne Voineskos; Vincenzo De Luca; Stuart Macgregor; Olga Likhodi; Laura Miller; Aristotle N Voineskos; James L Kennedy
Journal:  J Neural Transm (Vienna)       Date:  2009-01-28       Impact factor: 3.575

4.  Advances in the genetics of schizophrenia: will high-risk copy number variants be useful in clinical genetics or diagnostics?

Authors:  David A Collier; Evangelos Vassos; Simon Holden; Christine Patch; Philip McGuire; Cathryn Lewis
Journal:  F1000 Med Rep       Date:  2009-08-17

5.  Allelic association of G72/G30 with schizophrenia and bipolar disorder: a comprehensive meta-analysis.

Authors:  Jiajun Shi; Judith A Badner; Elliot S Gershon; Chunyu Liu
Journal:  Schizophr Res       Date:  2007-11-26       Impact factor: 4.939

6.  The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study.

Authors:  Diego Quattrone; Ulrich Reininghaus; Alex L Richards; Giada Tripoli; Laura Ferraro; Andrea Quattrone; Paolo Marino; Victoria Rodriguez; Edoardo Spinazzola; Charlotte Gayer-Anderson; Hannah E Jongsma; Peter B Jones; Caterina La Cascia; Daniele La Barbera; Ilaria Tarricone; Elena Bonora; Sarah Tosato; Antonio Lasalvia; Andrei Szöke; Celso Arango; Miquel Bernardo; Julio Bobes; Cristina Marta Del Ben; Paulo Rossi Menezes; Pierre-Michel Llorca; Jose Luis Santos; Julio Sanjuán; Manuel Arrojo; Andrea Tortelli; Eva Velthorst; Steven Berendsen; Lieuwe de Haan; Bart P F Rutten; Michael T Lynskey; Tom P Freeman; James B Kirkbride; Pak C Sham; Michael C O'Donovan; Alastair G Cardno; Evangelos Vassos; Jim van Os; Craig Morgan; Robin M Murray; Cathryn M Lewis; Marta Di Forti
Journal:  Transl Psychiatry       Date:  2021-08-10       Impact factor: 6.222

7.  Monoamine oxidase a and B gene polymorphisms and negative and positive symptoms in schizophrenia.

Authors:  Beatriz Camarena; Ana Fresán; Alejandro Aguilar; Raúl Escamilla; Ricardo Saracco; Jorge Palacios; Alfonso Tovilla; Humberto Nicolini
Journal:  ISRN Psychiatry       Date:  2012-04-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.